JP2022502350A5 - - Google Patents
Info
- Publication number
- JP2022502350A5 JP2022502350A5 JP2021510860A JP2021510860A JP2022502350A5 JP 2022502350 A5 JP2022502350 A5 JP 2022502350A5 JP 2021510860 A JP2021510860 A JP 2021510860A JP 2021510860 A JP2021510860 A JP 2021510860A JP 2022502350 A5 JP2022502350 A5 JP 2022502350A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- composition
- composition according
- interleukin
- rheumatoid arthritis
- Prior art date
Links
Applications Claiming Priority (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862724212P | 2018-08-29 | 2018-08-29 | |
| US62/724,212 | 2018-08-29 | ||
| US201862747301P | 2018-10-18 | 2018-10-18 | |
| US62/747,301 | 2018-10-18 | ||
| US201962798697P | 2019-01-30 | 2019-01-30 | |
| US62/798,697 | 2019-01-30 | ||
| US201962824399P | 2019-03-27 | 2019-03-27 | |
| US62/824,399 | 2019-03-27 | ||
| US201962856431P | 2019-06-03 | 2019-06-03 | |
| US62/856,431 | 2019-06-03 | ||
| US201962858443P | 2019-06-07 | 2019-06-07 | |
| US62/858,443 | 2019-06-07 | ||
| EP19192387 | 2019-08-19 | ||
| EP19192387.9 | 2019-08-19 | ||
| PCT/US2019/048460 WO2020047029A1 (en) | 2018-08-29 | 2019-08-28 | Methods and compositions for treating subjects having rheumatoid arthritis |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022502350A JP2022502350A (ja) | 2022-01-11 |
| JP2022502350A5 true JP2022502350A5 (https=) | 2022-09-02 |
| JPWO2020047029A5 JPWO2020047029A5 (https=) | 2022-09-02 |
| JP7504871B2 JP7504871B2 (ja) | 2024-06-24 |
Family
ID=67851236
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021510860A Active JP7504871B2 (ja) | 2018-08-29 | 2019-08-28 | 関節リウマチを有する対象を治療するための方法および組成物 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US11319375B2 (https=) |
| EP (1) | EP3843852A1 (https=) |
| JP (1) | JP7504871B2 (https=) |
| KR (1) | KR20210049871A (https=) |
| CN (1) | CN112955222A (https=) |
| AU (2) | AU2019329958B2 (https=) |
| BR (1) | BR112021003206A2 (https=) |
| CA (1) | CA3110891A1 (https=) |
| CL (1) | CL2021000483A1 (https=) |
| IL (1) | IL280824A (https=) |
| MA (1) | MA53481A (https=) |
| MX (2) | MX2021002422A (https=) |
| PH (1) | PH12021550416A1 (https=) |
| SG (1) | SG11202101674QA (https=) |
| TW (2) | TWI868074B (https=) |
| WO (1) | WO2020047029A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020261431A1 (en) | 2019-04-24 | 2021-12-09 | Regeneron Pharmaceuticals, Inc. | Methods of diagnosis and treatment of rheumatoid arthritis |
| FR3095698B1 (fr) * | 2019-05-03 | 2021-05-07 | Sinnovial | Procédé d’estimation de l’efficacité de traitement par un agent anti-CD20 chez un patient atteint de polyarthrite rhumatoïde et en réponse inadéquate a au moins une biothérapie |
| EP3980459A1 (en) | 2019-06-04 | 2022-04-13 | Sanofi Biotechnology | Compositions and methods for treating pain in subj ects with rheumatoid arthritis |
| IL298088A (en) * | 2020-05-26 | 2023-01-01 | Sanofi Biotechnology | The compositions containing an antibody against the interleukin-6 receptor for the treatment of rheumatoid arthritis and methods of using them |
| KR20230031015A (ko) * | 2021-08-26 | 2023-03-07 | 주식회사 이뮨메드 | 자가면역질환의 예방 또는 치료를 위한 항체의약품 |
| CN117138126B (zh) * | 2023-08-30 | 2024-04-09 | 江苏恰瑞生物科技有限公司 | 定向清除炎症因子il-6的过滤材料及过滤柱 |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5171840A (en) | 1988-01-22 | 1992-12-15 | Tadamitsu Kishimoto | Receptor protein for human B cell stimulatory factor-2 |
| US5605690A (en) | 1989-09-05 | 1997-02-25 | Immunex Corporation | Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor |
| EP1097945B1 (en) | 1991-03-18 | 2007-07-04 | New York University | Monoclonal and chimeric antibody specific for human tumor necrosis factor |
| EP0628639B1 (en) | 1991-04-25 | 1999-06-23 | Chugai Seiyaku Kabushiki Kaisha | Reconstituted human antibody against human interleukin 6 receptor |
| US5215534A (en) | 1991-12-02 | 1993-06-01 | Lawrence De Harde | Safety syringe system |
| KR100232688B1 (ko) | 1992-09-15 | 1999-12-01 | 스코트 쥐. 홀퀴스트 | 종양 괴사 인자 길항제를 함유하는 tnf-의존성 염증 치료용 제약 조성물 |
| PT783893E (pt) | 1994-10-07 | 2012-05-24 | Chugai Pharmaceutical Co Ltd | Inibição do crescimento anormal das células sinoviais usando antagonistas de il-6 como componente ativo |
| ZA971600B (en) | 1996-02-26 | 1997-09-22 | Merck & Co Inc | Treatment of macular edema. |
| US6670373B1 (en) | 1999-10-07 | 2003-12-30 | Eli Lilly And Company | Compounds and method for inhibiting MRP1 |
| US6629949B1 (en) | 2000-05-08 | 2003-10-07 | Sterling Medivations, Inc. | Micro infusion drug delivery device |
| US6659982B2 (en) | 2000-05-08 | 2003-12-09 | Sterling Medivations, Inc. | Micro infusion drug delivery device |
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| CA2817619A1 (en) | 2001-06-08 | 2002-12-08 | Abbott Laboratories (Bermuda) Ltd. | Methods of administering anti-tnf.alpha. antibodies |
| EP2062916A3 (en) | 2003-04-09 | 2009-08-19 | Genentech, Inc. | Therapy of autoimmune disease in a patient with an inadequate response to a TNF-Alpha inhibitor |
| CN1989439B (zh) | 2004-05-06 | 2010-12-29 | 美国政府健康及人类服务部 | 治疗葡萄膜炎的方法以及组合物 |
| EA014226B1 (ru) | 2004-07-26 | 2010-10-29 | Байоджен Айдек Ма Инк. | Антитела к cd154, их фрагменты и способы применения антител и фрагментов |
| CN101326195B9 (zh) | 2005-12-13 | 2022-11-11 | 伊莱利利公司 | 抗il-17抗体 |
| US20080131374A1 (en) | 2006-04-19 | 2008-06-05 | Medich John R | Uses and compositions for treatment of rheumatoid arthritis |
| ES2398076T3 (es) | 2006-06-02 | 2013-03-13 | Regeneron Pharmaceuticals, Inc. | Anticuerpos de alta afinidad contra el receptor de IL-6 humano |
| US8080248B2 (en) | 2006-06-02 | 2011-12-20 | Regeneron Pharmaceuticals, Inc. | Method of treating rheumatoid arthritis with an IL-6R antibody |
| FR2920033B1 (fr) | 2007-08-13 | 2014-08-22 | Snecma | Turbomachine avec diffuseur |
| TWI440469B (zh) | 2008-09-26 | 2014-06-11 | Chugai Pharmaceutical Co Ltd | Improved antibody molecules |
| JP4885308B2 (ja) | 2009-03-19 | 2012-02-29 | 中外製薬株式会社 | 改良された抗体分子を含有する製剤 |
| JO3030B1 (ar) | 2009-06-26 | 2016-09-05 | Galapagos Nv | مركب جديد مفيد لمعالجة الامراض التنكسية والالتهابات |
| EP2464666B1 (en) * | 2009-07-15 | 2018-03-21 | Eva Kovacs-Benke | Combination of a human interleukin-6 antagonist and a human interleukin-6 receptor antagonist in therapy of tumour diseases |
| JO3417B1 (ar) | 2010-01-08 | 2019-10-20 | Regeneron Pharma | الصيغ المستقرة التي تحتوي على الأجسام المضادة لمضاد مستقبل( interleukin-6 (il-6r |
| KR20130065662A (ko) | 2010-05-07 | 2013-06-19 | 조마 테크놀로지 리미티드 | ⅠＬ-1β 관련 병태의 치료 방법 |
| US9427531B2 (en) | 2010-06-28 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Auto-injector |
| EP2670438A4 (en) | 2011-02-03 | 2015-05-20 | Santarus Inc | SELECTION AND TREATMENT OF PATIENTS |
| TWI568888B (zh) | 2011-09-15 | 2017-02-01 | 第諾拉工業公司 | 氣體擴散電極及其製法和電化電解池 |
| TWI589299B (zh) | 2011-10-11 | 2017-07-01 | 再生元醫藥公司 | 用於治療類風濕性關節炎之組成物及其使用方法 |
| US9943594B2 (en) | 2011-10-11 | 2018-04-17 | Sanofi Biotechnology | Methods for the treatment of rheumatoid arthritis |
| US9248242B2 (en) | 2012-04-20 | 2016-02-02 | Safety Syringes, Inc. | Anti-needle stick safety device for injection device |
| CA2922732A1 (en) * | 2013-09-03 | 2015-03-12 | L. Douglas GRAHAM | Treatment methods for rheumatoid arthritis |
| AU2014352801B2 (en) * | 2013-11-22 | 2020-05-28 | Regeneron Pharmaceuticals, Inc. | Compositions for the treatment of rheumatoid arthritis and methods of using same |
| WO2015116852A1 (en) * | 2014-01-29 | 2015-08-06 | Regeneron Pharmaceuticals, Inc. | Methods for treating rheumatoid arthritis by administering an il-6r antibody |
| AU2015317905A1 (en) | 2014-09-16 | 2017-03-16 | Regeneron Pharmaceuticals, Inc. | Compositions for improving the health related quality of life of rheumatoid arthritis patients |
| IL319993A (en) | 2015-11-03 | 2025-06-01 | Sanofi Biotechnology | Compositions comprising il6r antibodies for the treatment of uveitis and macular edema and methods of using same |
| BR112018067851A2 (pt) | 2016-03-07 | 2019-02-05 | Regeneron Pharma | composições e métodos para o tratamento de artrite reumatoide |
| EP3216461A1 (en) * | 2016-03-07 | 2017-09-13 | Sanofi Biotechnology | Compositions and methods for treating rheumatoid arthritis |
-
2019
- 2019-08-28 AU AU2019329958A patent/AU2019329958B2/en active Active
- 2019-08-28 TW TW108130759A patent/TWI868074B/zh active
- 2019-08-28 BR BR112021003206-1A patent/BR112021003206A2/pt unknown
- 2019-08-28 JP JP2021510860A patent/JP7504871B2/ja active Active
- 2019-08-28 CN CN201980065880.1A patent/CN112955222A/zh active Pending
- 2019-08-28 WO PCT/US2019/048460 patent/WO2020047029A1/en not_active Ceased
- 2019-08-28 KR KR1020217008732A patent/KR20210049871A/ko not_active Ceased
- 2019-08-28 EP EP19763150.0A patent/EP3843852A1/en active Pending
- 2019-08-28 MA MA053481A patent/MA53481A/fr unknown
- 2019-08-28 MX MX2021002422A patent/MX2021002422A/es unknown
- 2019-08-28 CA CA3110891A patent/CA3110891A1/en active Pending
- 2019-08-28 US US16/553,338 patent/US11319375B2/en active Active
- 2019-08-28 SG SG11202101674QA patent/SG11202101674QA/en unknown
- 2019-08-28 TW TW113147810A patent/TW202532441A/zh unknown
-
2021
- 2021-02-11 IL IL280824A patent/IL280824A/en unknown
- 2021-02-25 CL CL2021000483A patent/CL2021000483A1/es unknown
- 2021-02-26 MX MX2025010592A patent/MX2025010592A/es unknown
- 2021-02-26 PH PH12021550416A patent/PH12021550416A1/en unknown
-
2022
- 2022-03-23 US US17/701,748 patent/US20230059376A1/en not_active Abandoned
-
2025
- 2025-05-09 AU AU2025203365A patent/AU2025203365A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022502350A5 (https=) | ||
| Smolen et al. | Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial | |
| Castañeda et al. | Adult-onset Still's disease: advances in the treatment | |
| JP6657089B2 (ja) | 関節リウマチを治療するための組成物およびこれを使用する方法 | |
| JP2024069453A5 (https=) | ||
| Thompson et al. | Anti cytokine therapy in chronic inflammatory arthritis | |
| Md Yusof et al. | Targeting interleukin-6 in rheumatoid arthritis | |
| CA3116725C (en) | Secukinumab for use in the treatment of psoriatic arthritis | |
| JP7288927B2 (ja) | 乾癬性関節炎患者における構造的損傷の進行を阻害するためのｉｌ－１７アンタゴニストの使用 | |
| JP2024123249A (ja) | 関節リウマチの治療における、又は、鎮痛剤としての使用のための抗体中和ｇｍ－ｃｓｆ | |
| TWI868074B (zh) | 用來治療患有類風濕性關節炎之個體的方法及組成物 | |
| AU2016250388A1 (en) | Treatment for rheumatoid arthritis | |
| JP2018515493A5 (https=) | ||
| Bakshi et al. | New therapeutic avenues in SLE | |
| Nishimoto et al. | Assessment of the validity of the 28-joint disease activity score using erythrocyte sedimentation rate (DAS28-ESR) as a disease activity index of rheumatoid arthritis in the efficacy evaluation of 24-week treatment with tocilizumab: subanalysis of the SATORI study | |
| Zhao et al. | The off-label uses profile of tofacitinib in systemic rheumatic diseases | |
| JP2020045351A (ja) | 関節リウマチを治療するための組成物およびこれを使用する方法 | |
| JP7841752B2 (ja) | 関節リウマチを有する対象における非炎症性疼痛を治療するための組成物および方法 | |
| JPWO2020047029A5 (https=) | ||
| Baronaite Hansen et al. | Secukinumab for the treatment of psoriatic arthritis | |
| KR20210060582A (ko) | 화농성 한선염 치료를 위한 범-elr+ cxc 케모카인 항체 | |
| AU2014259526B2 (en) | Methods of treating ankylosing spondylitis using IL-17 antagonists | |
| Mochizuki et al. | Evaluation of the efficacy and safety of etanercept 50 mg once weekly in Japanese patients with rheumatoid arthritis and comparison with 25 mg etanercept twice weekly | |
| Pamukcu et al. | Which anti-TNF is most effective for my patient? Which one should I choose? | |
| Ogata et al. | IL-6 Targeting strategy for rheumatoid arthritis |